Oral doxifluridine plus levoleucovorin in elderly patients with advanced breast cancer
- 15 September 1998
- Vol. 83 (6) , 1136-1141
- https://doi.org/10.1002/(sici)1097-0142(19980915)83:6<1136::aid-cncr12>3.0.co;2-6
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Clinical aspects of cancer in the elderly. Treatment decisions, treatment choices, and follow-upCancer, 1994
- Cancer Treatment and Age: Patient PerspectivesJNCI Journal of the National Cancer Institute, 1993
- Phase II study of an oral combination of doxifluridine, prednimustine and idarubicin (FUPRIDA) for first line treatment of advanced breast cancerAnnals of Oncology, 1993
- Chemotherapy of Metastatic Breast Cancer in the ElderlyPublished by American Medical Association (AMA) ,1992
- Optimal two-stage designs for phase II clinical trialsControlled Clinical Trials, 1989
- A phase II study of doxifluridine in patients with advanced breast cancerEuropean Journal of Cancer and Clinical Oncology, 1988
- Cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy in women more than 65 years old with advanced breast cancer: the elimination of age trends in toxicity by using doses based on creatinine clearance.Journal of Clinical Oncology, 1984
- Reporting results of cancer treatmentCancer, 1981
- Dose-Response Effect of Adjuvant Chemotherapy in Breast CancerNew England Journal of Medicine, 1981
- Dose: A critical factor in cancer chemotherapyThe American Journal of Medicine, 1980